Of the more than 30 antiseizure medications, three are seen as "pretty safe" in pregnancy, and another seven or so are known ...
The progression-free survival (PFS) rate at 5 years improved from 40.8% with active monitoring and no disease-specific ...
With an accuracy of 86%, the biomarker panel has the potential to be clinically useful in diagnosis, management, and ...
NVS' Fabhalta improves the average hemoglobin level compared to baseline in adult patients with PNH who switched from anti-C5 ...
Novartis has reported positive topline outcomes from the multicentre Phase IIIB APPULSE-PNH trial of oral Fabhalta (iptacopan ...
Management holds 11th Annual ESG Investor Virtual Event on December 9 at 10 am. NVS ).webcasts.com/starthere.jsp?ei=1689776&tp_key=9312b9a422′ target= ‘_blank’; rel=’nofollow’>Webcast Link Discover ...
Analysts at Citi are not too concerned as they believes that even while the passage of the Biosecure Act appears to have been ...
Novartis suffered a legal setback on Wednesday as the company failed to persuade a U.S. appeals court to halt MSN ...
The spinout startup has turned to Wefunder for its pre-seed raise while also landing support from a main ecosystem partner.
High bad cholesterol is a risk factor for a common type of heart disease, yet approximately 40% of Americans living with high cholesterol don't know they have it and don't treat it1,2. Watch our Local ...
CITRYLL RAISES EUR 85 MILLION SERIES B TO ADVANCE NOVEL NET-TARGETING THERAPY FOR IMMUNE-MEDIATED INFLAMMATORY DISORDERSFinancing co-led by ...
The Max Foundation expands collaboration with Novartis to include access to innovative treatment for paroxysmal nocturnal hemoglobinuria: Seattle, Washington Monday, December 9, 2 ...